Gilead Offers Patient Assistance Through AccessConnect

Gilead offers eligible patients receiving treatment with Zydelig (idelalisib) ease of access, affordability, and adherence support through its patient assistance program, Zydelig AccessConnect. Zydelig is a kinase inhibitor approved for the treatment of relapsed follicular B-cell non-Hodgkin lymphoma, relapsed small lymphocytic lymphoma, and in combination with rituximab in the treatment of relapsed chronic lymphocytic leukemia.

What Patients Will Receive

Qualified patients enrolled in Zydelig AccessConnect will receive access, financial, and adherence support, including the following:

  • Access Support. Case Specialists at Zydelig AccessConnect can help eligible patients and their providers by ensuring timely delivery of their medications, explaining the benefits of Medicare Part D, and providing a better understanding of the details and requirements of their insurance coverage with regard to Zydelig.
  • Financial Support. Uninsured patients may be eligible to receive Zydelig free of charge through the Zydelig AccessConnect Patient Assistance Program, and patients with commercial or private insurance may qualify for copay coupon assistance. Referrals to independent foundations capable of offering financial support may be available for patients with Medicare.
  • Adherence Support. With the help of Zydelig AccessConnect’s Patient Support Nurses, eligible patients can receive tips on how to join support networks, take their prescribed medication as advised, and communicate with their provider regarding their treatment.

Copay Coupon Card

To qualify for the Copay Coupon Card, patients must meet the following eligibility requirements:
  • They must have a valid prescription for Zydelig
  • The patient must reside in the United States, Puerto Rico, Guam, or the Virgin Islands
  • They cannot be enrolled in any state-funded or federally funded health insurance programs (eg, Medicaid, Medicare, or Medigap)
Using the online enrollment form available at, eligible patients can sign up for the Copay Coupon Card themselves and, right after doing so, can print out a copy of their card. The card is valid for 1 year following the date of receipt, or for 15 fills within that 12-month time span.

What Patients Will Receive
The Zydelig AccessConnect Copay Coupon Card will cover out-of-pocket costs for Zydelig after the first $5 of each prescription fill, for up to a maximum of 25% of the catalog price of a 1-year supply of Zydelig.

Government Insurance Support

Patients who are enrolled in government health insurance programs (eg, Medicare) but cannot afford the full out-of-pocket costs for the copays and coinsurance may be eligible for assistance from independent foundations. Information about independent assistance foundations and referrals is available at­insurance-support.

Patient Assistance Program

Patients who do not have insurance coverage for Zydelig may be eligible to receive the medication free of charge through the Zydelig AccessConnect Patient Assistance Program. To qualify they must reside in the United States, be enrolled in Zydelig AccessConnect, and be receiving care from a US physician. Additionally, they cannot have insurance coverage for the requested medication. For more information about the Patient Assistance Pro­gram, call (844) 622-2377.

Zydelig QuickStart Program

The Zydelig QuickStart Program gives eligible patients who have an insurance-coverage delay of >5 business days rapid access to a free, 1-time, 30-day supply of Zydelig. The purchase of Zydelig is not compulsory for participation in the program, but certain restrictions may apply. Patients can enroll in the Zydelig QuickStart Program by filling out section 8 of the Zydelig AccessConnect enrollment form. Section 8 of the enrollment form also includes detailed information about eligibility criteria and what patients can expect to receive from the Zydelig QuickStart Program.

Subscribe to
Oncology Practice Management

Stay up to date with oncology news & updates by subscribing to recieve the free OPM print publications or weekly e‑Newsletter.

I'd like to recieve: